Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000899243-21-036426

Chief Executive Officer acquired 34,007 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd Chief Executive Officer 2021-09-17 Conversion +34,007 1,696,343 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd Chief Executive Officer 2021-09-17 Conversion · Series A Preferred Stock −13,093 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…